List of Tables
Table 1. Global Alzheimer's Disease Diagnostic Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Genetic Testing
Table 3. Key Players of Neurological Exam
Table 4. Key Players of Mini-Mental State Exam(MMSE)
Table 5. Key Players of Brain Imaging
Table 6. Key Players of Other
Table 7. Global Alzheimer's Disease Diagnostic Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Alzheimer's Disease Diagnostic Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 9. Global Alzheimer's Disease Diagnostic Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Alzheimer's Disease Diagnostic Revenue Market Share by Region (2017-2022)
Table 11. Global Alzheimer's Disease Diagnostic Revenue by Players (2017-2022) & (US$ Million)
Table 12. Global Alzheimer's Disease Diagnostic Market Share by Players (2017-2022)
Table 13. Global Top Alzheimer's Disease Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Diagnostic as of 2021)
Table 14. Ranking of Global Top Alzheimer's Disease Diagnostic Companies by Revenue (US$ Million) in 2021
Table 15. Global 5 Largest Players Market Share by Alzheimer's Disease Diagnostic Revenue (CR5 and HHI) & (2017-2022)
Table 16. Key Players Headquarters and Area Served
Table 17. Key Players Alzheimer's Disease Diagnostic Product Solution and Service
Table 18. Date of Key Manufacturers Enter into Alzheimer's Disease Diagnostic Market
Table 19. Mergers & Acquisitions, Expansion Plans
Table 20. Global Alzheimer's Disease Diagnostic Market Size by Type (2017-2022) & (US$ Million)
Table 21. Global Alzheimer's Disease Diagnostic Revenue Market Share by Type (2017-2022)
Table 22. Global Alzheimer's Disease Diagnostic Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 23. Global Alzheimer's Disease Diagnostic Revenue Market Share by Type (2023-2028)
Table 24. Global Alzheimer's Disease Diagnostic Market Size by Application (2017-2022) & (US$ Million)
Table 25. Global Alzheimer's Disease Diagnostic Revenue Market Share by Application (2017-2022)
Table 26. Global Alzheimer's Disease Diagnostic Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 27. Global Alzheimer's Disease Diagnostic Revenue Market Share by Application (2023-2028)
Table 28. North America Alzheimer's Disease Diagnostic Revenue by Company (2020-2022) & (US$ Million)
Table 29. North America Alzheimer's Disease Diagnostic Revenue by Type (2017-2022) & (US$ Million)
Table 30. North America Alzheimer's Disease Diagnostic Revenue by Type (2023-2028) & (US$ Million)
Table 31. North America Alzheimer's Disease Diagnostic Revenue by Application (2017-2022) & (US$ Million)
Table 32. North America Alzheimer's Disease Diagnostic Revenue by Application (2023-2028) & (US$ Million)
Table 33. North America Alzheimer's Disease Diagnostic Revenue by Country (2017-2022) & (US$ Million)
Table 34. North America Alzheimer's Disease Diagnostic Revenue by Country (2023-2028) & (US$ Million)
Table 35. Europe Alzheimer's Disease Diagnostic Revenue by Company (2020-2022) & (US$ Million)
Table 36. Europe Alzheimer's Disease Diagnostic Revenue by Type (2017-2022) & (US$ Million)
Table 37. Europe Alzheimer's Disease Diagnostic Revenue by Type (2023-2028) & (US$ Million)
Table 38. Europe Alzheimer's Disease Diagnostic Revenue by Application (2017-2022) & (US$ Million)
Table 39. Europe Alzheimer's Disease Diagnostic Revenue by Application (2023-2028) & (US$ Million)
Table 40. Europe Alzheimer's Disease Diagnostic Revenue by Country (2017-2022) & (US$ Million)
Table 41. Europe Alzheimer's Disease Diagnostic Revenue by Country (2023-2028) & (US$ Million)
Table 42. Asia Pacific Alzheimer's Disease Diagnostic Revenue by Company (2020-2022) & (US$ Million)
Table 43. Asia Pacific Alzheimer's Disease Diagnostic Revenue by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Alzheimer's Disease Diagnostic Revenue by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Alzheimer's Disease Diagnostic Revenue by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Alzheimer's Disease Diagnostic Revenue by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Alzheimer's Disease Diagnostic Revenue by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Alzheimer's Disease Diagnostic Revenue by Region (2023-2028) & (US$ Million)
Table 49. Latin America Alzheimer's Disease Diagnostic Revenue by Company (2020-2022) & (US$ Million)
Table 50. Latin America Alzheimer's Disease Diagnostic Revenue by Type (2017-2022) & (US$ Million)
Table 51. Latin America Alzheimer's Disease Diagnostic Revenue by Type (2023-2028) & (US$ Million)
Table 52. Latin America Alzheimer's Disease Diagnostic Revenue by Application (2017-2022) & (US$ Million)
Table 53. Latin America Alzheimer's Disease Diagnostic Revenue by Application (2023-2028) & (US$ Million)
Table 54. Latin America Alzheimer's Disease Diagnostic Revenue by Country (2017-2022) & (US$ Million)
Table 55. Latin America Alzheimer's Disease Diagnostic Revenue by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Alzheimer's Disease Diagnostic Revenue by Company (2020-2022) & (US$ Million)
Table 57. Middle East and Africa Alzheimer's Disease Diagnostic Revenue by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Alzheimer's Disease Diagnostic Revenue by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Alzheimer's Disease Diagnostic Revenue by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Alzheimer's Disease Diagnostic Revenue by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Alzheimer's Disease Diagnostic Revenue by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Alzheimer's Disease Diagnostic Revenue by Country (2023-2028) & (US$ Million)
Table 63. Eli Lilly Company Details
Table 64. Eli Lilly Business Overview
Table 65. Eli Lilly Alzheimer's Disease Diagnostic Product and Services
Table 66. Eli Lilly Alzheimer's Disease Diagnostic Revenue in Alzheimer's Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 67. Eli Lilly Alzheimer's Disease Diagnostic SWOT Analysis
Table 68. Eli Lilly Recent Developments
Table 69. TauRx Company Details
Table 70. TauRx Business Overview
Table 71. TauRx Alzheimer's Disease Diagnostic Product and Services
Table 72. TauRx Alzheimer's Disease Diagnostic Revenue in Alzheimer's Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 73. TauRx Alzheimer's Disease Diagnostic SWOT Analysis
Table 74. TauRx Recent Developments
Table 75. Alector Company Details
Table 76. Alector Business Overview
Table 77. Alector Alzheimer's Disease Diagnostic Product and Services
Table 78. Alector Alzheimer's Disease Diagnostic Revenue in Alzheimer's Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 79. Alector Alzheimer's Disease Diagnostic SWOT Analysis
Table 80. Alector Recent Developments
Table 81. Accera Company Details
Table 82. Accera Business Overview
Table 83. Accera Alzheimer's Disease Diagnostic Product and Services
Table 84. Accera Alzheimer's Disease Diagnostic Revenue in Alzheimer's Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 85. Accera Alzheimer's Disease Diagnostic SWOT Analysis
Table 86. Accera Recent Developments
Table 87. Treventis Company Details
Table 88. Treventis Business Overview
Table 89. Treventis Alzheimer's Disease Diagnostic Product and Services
Table 90. Treventis Alzheimer's Disease Diagnostic Revenue in Alzheimer's Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 91. Treventis Alzheimer's Disease Diagnostic SWOT Analysis
Table 92. Treventis Recent Developments
Table 93. Neuro-Bio Company Details
Table 94. Neuro-Bio Business Overview
Table 95. Neuro-Bio Alzheimer's Disease Diagnostic Product and Services
Table 96. Neuro-Bio Alzheimer's Disease Diagnostic Revenue in Alzheimer's Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 97. Neuro-Bio Alzheimer's Disease Diagnostic SWOT Analysis
Table 98. Neuro-Bio Recent Developments
Table 99. Cognition Therapeutics Company Details
Table 100. Cognition Therapeutics Business Overview
Table 101. Cognition Therapeutics Alzheimer's Disease Diagnostic Product and Services
Table 102. Cognition Therapeutics Alzheimer's Disease Diagnostic Revenue in Alzheimer's Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 103. Cognition Therapeutics Alzheimer's Disease Diagnostic SWOT Analysis
Table 104. Cognition Therapeutics Recent Developments
Table 105. Alzheimer's Disease Diagnostic Market Trends
Table 106. Alzheimer's Disease Diagnostic Market Drivers
Table 107. Alzheimer's Disease Diagnostic Market Challenges
Table 108. Alzheimer's Disease Diagnostic Market Restraints
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alzheimer's Disease Diagnostic Sales Market Share by Type: 2021 VS 2028
Figure 2. Genetic Testing Features
Figure 3. Neurological Exam Features
Figure 4. Mini-Mental State Exam(MMSE) Features
Figure 5. Brain Imaging Features
Figure 6. Other Features
Figure 7. Global Alzheimer's Disease Diagnostic Sales Market Share by Application: 2021 VS 2028
Figure 8. Clinics Case Studies
Figure 9. Hospitals Case Studies
Figure 10. Diagnostic Centers Case Studies
Figure 11. Other Case Studies
Figure 12. Alzheimer's Disease Diagnostic Report Years Considered
Figure 13. Global Alzheimer's Disease Diagnostic Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Alzheimer's Disease Diagnostic Market Size 2017-2028 (US$ Million)
Figure 15. Global Alzheimer's Disease Diagnostic Market Size Market Share by Region: 2021 VS 2028
Figure 16. Global Alzheimer's Disease Diagnostic Revenue Market Share by Region in 2017 VS 2022
Figure 17. Global Top 10 Alzheimer's Disease Diagnostic Countries Ranking by Market Size (US$ Million) in 2021
Figure 18. Global Alzheimer's Disease Diagnostic Market Share by Players in 2021
Figure 19. Global Top Alzheimer's Disease Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Diagnostic as of 2021)
Figure 20. The Top 10 and 5 Players Market Share by Alzheimer's Disease Diagnostic Revenue in 2021
Figure 21. North America Alzheimer's Disease Diagnostic Revenue Market Share by Company in 2021
Figure 22. North America Alzheimer's Disease Diagnostic Revenue Market Share by Type (2017-2028)
Figure 23. North America Alzheimer's Disease Diagnostic Revenue Market Share by Application (2017-2028)
Figure 24. North America Alzheimer's Disease Diagnostic Revenue Share by Country (2017-2028)
Figure 25. U.S. Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 26. Canada Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 27. Europe Alzheimer's Disease Diagnostic Revenue Market Share by Company in 2021
Figure 28. Europe Alzheimer's Disease Diagnostic Revenue Market Share by Type (2017-2028)
Figure 29. Europe Alzheimer's Disease Diagnostic Revenue Market Share by Application (2017-2028)
Figure 30. Europe Alzheimer's Disease Diagnostic Revenue Share by Country (2017-2028)
Figure 31. Germany Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 32. France Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 33. U.K. Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 34. Italy Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 35. Russia Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 36. Asia Pacific Alzheimer's Disease Diagnostic Revenue Market Share by Company in 2021
Figure 37. Asia Pacific Alzheimer's Disease Diagnostic Revenue Market Share by Type (2017-2028)
Figure 38. Asia Pacific Alzheimer's Disease Diagnostic Revenue Market Share by Application (2017-2028)
Figure 39. Asia Pacific Alzheimer's Disease Diagnostic Revenue Share by Region (2017-2028)
Figure 40. China Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 41. Japan Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 42. South Korea Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 43. India Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 44. Australia Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 45. Taiwan Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 46. Indonesia Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 47. Thailand Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 48. Malaysia Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 49. Philippines Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 50. Vietnam Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 51. Latin America Alzheimer's Disease Diagnostic Revenue Market Share by Company in 2021
Figure 52. Latin America Alzheimer's Disease Diagnostic Revenue Market Share by Type (2017-2028)
Figure 53. Latin America Alzheimer's Disease Diagnostic Revenue Market Share by Application (2017-2028)
Figure 54. Latin America Alzheimer's Disease Diagnostic Revenue Share by Country (2017-2028)
Figure 55. Mexico Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 56. Brazil Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 57. Argentina Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 58. Middle East and Africa Alzheimer's Disease Diagnostic Revenue Market Share by Company in 2021
Figure 59. Middle East and Africa Alzheimer's Disease Diagnostic Revenue Market Share by Type (2017-2028)
Figure 60. Middle East and Africa Alzheimer's Disease Diagnostic Revenue Market Share by Application (2017-2028)
Figure 61. Middle East and Africa Alzheimer's Disease Diagnostic Revenue Share by Country (2017-2028)
Figure 62. Turkey Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 63. Saudi Arabia Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 64. U.A.E Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 65. Eli Lilly Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2017-2022)
Figure 66. TauRx Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2017-2022)
Figure 67. Alector Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2017-2022)
Figure 68. Accera Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2017-2022)
Figure 69. Treventis Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2017-2022)
Figure 70. Neuro-Bio Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2017-2022)
Figure 71. Cognition Therapeutics Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2017-2022)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed